德特拉贝纳的安全性评估:来自FAERS数据库的现实世界不良事件分析
Yanping Shu1, Yuanhe Wang2, Jiaoying Liu1
1Department of Psychiatry of Women and Children, The Second People's Hospital of Guizhou Province, Guiyang, China.
Frontiers in pharmacology
|January 7, 2025
概括
这项研究分析了现实世界中的德特拉贝纳安全数据,确定了精神病学和神经系统中的关键不良事件. 研究结果强调需要监测晚期动症患者的潜在副作用,如抑郁症和自杀念头.
科学领域:
- 药物监督和药物安全研究.
- 治疗干预的现实世界证据生成.
- 对神经学和精神病学药物的不良事件的分析.
背景情况:
- 杜特特拉贝纳是治疗迟性运动障碍症 (TD) 的关键药物.
- 营销后监测对于了解药物安全性概况至关重要.
- 对于deutetrabenazine,大规模的真实世界的安全数据存在差距.
研究的目的:
- 通过FAERS数据库进行deutetrabenazine的药监测分析.
- 识别和评估与deutetrabenazine相关的安全信号.
- 为医疗保健专业人员提供关于deutetrabenazine安全性的临床见解.
主要方法:
- 从FDA不良事件报告系统 (FAERS) 从2017年第一季度到2024年第一季度收集的不良事件 (AE) 数据.
- 采用了统计方法,包括报告几率比率 (ROR),比例报告比率 (PRR),贝叶斯信任传播神经网络 (BCPNN) 和经验贝叶斯几何平均值 (EBGM) 进行信号检测.
- 标准化AE使用医学监管活动词典 (MedDRA) 23.0版本,按器官系统类 (SOC) 和首选术语 (PT) 分类.
主要成果:
- 分析了3583个AE,其中deutetrabenazine是主要的可疑药物,涵盖23个SOC.
- 在神经疾病 (ROR=3.02) 和精神疾病 (ROR=4.15) 中确定了显著的安全信号.
- 常见的PT包括无效的药物,运动障碍,抑郁症,昏昏欲睡和自杀念头;注意到了新的信号,如舌头推进,吟和唾液流出.
结论:
- 德特拉贝纳的疗效可能与多个器官系统的潜在不良影响有关.
- 在临床实践中,建议对精神病,神经病,胃肠道和呼吸系统不良事件进行密切监测.
- 这项药监测研究为deutetrabenazine提供了有价值的真实世界的安全见解.
相关概念视频
01:25Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
01:19Pharmacovigilance
728
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
728
01:20Antiepileptic Drugs: Potassium Channel Activators
117
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
117